News

A part 1b trial discovered that Jaypirca plus Venclexta, with or with out Rituxan, could also be a promising remedy choice for sufferers...

Sue McCarthy obtained diagnoses of breast most cancers in 2001 and lung most cancers in 2018. Make amends for all of Sue's blogs...

The FDA has authorised an Itovebi mixture for choose sufferers with superior or metastatic breast most cancers. The Meals and Drug Administration (FDA)...

SBRT versus hypofractionated CRT confirmed no variations in advantages for sufferers with stage 1 NSCLC, a research demonstrated. Radiation remedy strategies, together with...

Dato-DXd demonstrated vital enhancements in progression-free survival for sufferers with inoperable or metastatic HR-positive/HER2-negative breast most cancers.Datopotamab deruxtecan (Dato-DXd) demonstrated vital enhancements in...